8-K//Current report
Maze Therapeutics, Inc. 8-K
Accession 0000950170-25-071357
$MAZECIK 0001842295operating
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:04 PM ET
Size
277.7 KB
Accession
0000950170-25-071357
Documents
- 8-Kmaze-20250514.htmPrimary
8-K
- EX-99.1maze-ex99_1.htm
EX-99.1
- GRAPHICimg92905542_0.jpg
GRAPHIC
- EX-101.SCHmaze-20250514.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-25-071357-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLmaze-20250514_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Maze Therapeutics, Inc.
CIK 0001842295
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001842295
Filing Metadata
- Form type
- 8-K
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 4:04 PM ET
- Size
- 277.7 KB